Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Tissue Eng B Rev 17:165176 Lovric-Bencic M, Sikiric P, Hanzevacki JS, Seiwerth S, Rogic D, Kusec V, Aralica G, Konjevoda P, Batelja L, Blagaic AB (2004) Doxorubicine-congestive heart failure-increased big endothelin-1 plasma concentration: reversal by amlodipine, losartan, and gastric pentadecapeptide BPC157 in rat and mouse
However, long-term human safety data is still being established
The present consensus statements can contribute to the development of effective approaches, aiming for the overall improvement of individual and public health
Comprehensive documentation of treatment rationale, patient consent processes, and clinical monitoring should be maintained given the experimental nature of these interventions and potential regulatory scrutiny
Availability varies by country
US$ 28.21
US$ 27.98
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120470-2b143445f1924b8a9050fb3a639779df.jpg)
US$ 29.78
US$ 25.78
